STEREOTACTIC BODY RADIOTHERAPY FOR OLIGOPROGRESSIVE OVARIAN CANCER PATIENTS TREATED DURING PARP INHIBITOR MAINTENANCE: EFFICACY AND ADVERSE EVENTS FROM THE EPIMETHEO RETROSPECTIVE STUDY.
Gabriella M, Donato P, Maura C, Donatella R, Graziana R, Simona L, Vanda S, Aida DS, Vittoria B, Valeria E, Elisabetta P, Claudia M, Grazia DM, Eleonora P, Rosa A, Viola L, Roberta G, Raffaella R, Andrea RS, Savino C, Anna F, Antonietta GM, Giovanni S, Francesco D, Gabriella F.
Gabriella M, et al. Among authors: raffaella r.
Int J Radiat Oncol Biol Phys. 2024 Sep 8:S0360-3016(24)03369-8. doi: 10.1016/j.ijrobp.2024.09.010. Online ahead of print.
Int J Radiat Oncol Biol Phys. 2024.
PMID: 39255875